IL156864A0 - Polynucleotides and polypeptides and their use in metabolic disorders - Google Patents

Polynucleotides and polypeptides and their use in metabolic disorders

Info

Publication number
IL156864A0
IL156864A0 IL15686402A IL15686402A IL156864A0 IL 156864 A0 IL156864 A0 IL 156864A0 IL 15686402 A IL15686402 A IL 15686402A IL 15686402 A IL15686402 A IL 15686402A IL 156864 A0 IL156864 A0 IL 156864A0
Authority
IL
Israel
Prior art keywords
polynucleotides
polypeptides
metabolic disorders
metabolic
disorders
Prior art date
Application number
IL15686402A
Other languages
English (en)
Original Assignee
Genset Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genset Sa filed Critical Genset Sa
Publication of IL156864A0 publication Critical patent/IL156864A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Cardiology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL15686402A 2001-01-16 2002-01-15 Polynucleotides and polypeptides and their use in metabolic disorders IL156864A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26223501P 2001-01-16 2001-01-16
US32297301P 2001-09-14 2001-09-14
PCT/IB2002/001461 WO2002066505A2 (en) 2001-01-16 2002-01-15 Gmg-3, gmg-4, and gmg-6 polynucleotides and polypeptides and uses thereof

Publications (1)

Publication Number Publication Date
IL156864A0 true IL156864A0 (en) 2004-02-08

Family

ID=26949103

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15686402A IL156864A0 (en) 2001-01-16 2002-01-15 Polynucleotides and polypeptides and their use in metabolic disorders

Country Status (7)

Country Link
US (1) US7326678B2 (ja)
EP (1) EP1351983A2 (ja)
JP (1) JP2004531234A (ja)
AU (1) AU2002249529B2 (ja)
CA (1) CA2433841A1 (ja)
IL (1) IL156864A0 (ja)
WO (1) WO2002066505A2 (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060089311A1 (en) * 2001-11-28 2006-04-27 Deno Dialvnas Agonists and antagonists of ryzn for the treatment of metabolic disorders
WO2003090514A2 (en) * 2002-04-26 2003-11-06 Zymogenetics, Inc. Adipocyte complement related protein zacrp14
BR0318307A (pt) * 2003-05-21 2006-07-11 Ares Trading Sa polipeptìdeo, molécula de ácido nucleico purificado, vetor, célula hospedeira, ligante, composto, método para diagnosticar uma doença em um paciente, uso de um polipeptìdeo, composição farmacêutica, composição de vacina, métodos para tratar uma doença para monitorar o tratamento terapêutico de doença em um paciente, método para a identificação de um composto que é efetivo no tratamento e/ou diagnóstico de doença, kit, e, animal não-humano transgênico ou knockout

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL134011A0 (en) 1997-07-18 2001-04-30 Zymogenetics Inc Adipocyte-specific protein homologs
ATE324443T1 (de) * 1997-08-26 2006-05-15 Zymogenetics Inc Für adipozyten spezifische protein homologe
AU5129800A (en) * 1999-05-11 2000-11-21 Incyte Genomics, Inc. Extracellular matrix and adhesion-associated proteins

Also Published As

Publication number Publication date
JP2004531234A (ja) 2004-10-14
WO2002066505A3 (en) 2003-02-20
EP1351983A2 (en) 2003-10-15
US7326678B2 (en) 2008-02-05
WO2002066505A2 (en) 2002-08-29
US20050239696A1 (en) 2005-10-27
AU2002249529B2 (en) 2007-03-22
CA2433841A1 (en) 2002-08-29

Similar Documents

Publication Publication Date Title
EP1601758A4 (en) POLYNUCLEOTIDES AND POLYPEPTIDES IN PLANTS
EP1583820A4 (en) ASSOCIATED POLYNUCLEOTIDES AND POLYPEPTIDES ASSOCIATED WITH THE NF-KB WAY
HUP0500989A2 (en) Animicrobial polypeptides and their uses
HUP0500992A3 (en) Tacis and br3 polypeptides and uses thereof
PL373484A1 (en) Vanilloid receptor ligands and their use in treatments
EP1379540A4 (en) POLYNUCLEOTIDES AND POLYPEPTIDES ASSOCIATED WITH NF-KB PATH
EP1578769A4 (en) PEPTIDES AND THEIR USE TO DARK THE SKIN
AU2001265009A1 (en) Human polynucleotides and polypeptides encoded thereby
IL153568A (en) Novel polypeptides and polynucleotides
IL160229A0 (en) Polynucleotides, polypeptides encoded thereby and their use
IL159872A0 (en) Gmg-2 polypeptides and their use
AU2001266229A1 (en) Hcn polypeptides and polynucleotides and their use in therapy
EP1409661A4 (en) HDAC9 POLYPEPTIDES AND POLYNUCLEOTIDES AND USES THEREOF
AU2001280608A1 (en) Human polynucleotides and polypeptides encoded thereby
GB0125131D0 (en) Improvements in and relating to conatiners
EP1389041A4 (en) IMPROVEMENTS RELATING TO WIPES
IL156863A0 (en) Polynucleotides and polypeptides and their use in metabolic disorders
IL156864A0 (en) Polynucleotides and polypeptides and their use in metabolic disorders
PL363290A1 (en) 1k-polyurethane lacquer and use thereof
AU2003223064A8 (en) Krib polynucleotides and polypeptides and uses thereof in the treatment of metabolic disorders
IL162507A (en) Use of ifnar2 mutants in the manufacture of medicaments
AU5719501A (en) Novel human kinase proteins and polynucleotides encoding the same
IL163683A0 (en) Substituted 3-phenyl-5-alkoxy-1,3,4,-oxadiazol-2-ones, their preparation and use in medicaments
EP1365801A4 (en) METHOD AND MATERIALS IN CONNECTION WITH FIBULIN-LIKE POLYPEPTIDES AND POLYNUCLEOTIDES
AU7151601A (en) Novel human gaba receptors and polynucleotides encoding the same